Rodney Young
2023 - RAPT Therapeutics
In 2023, Rodney Young earned a total compensation of $2.2M as Chief Financial Officer at RAPT Therapeutics, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,000 |
|---|---|
| Option Awards | $1,558,662 |
| Salary | $459,000 |
| Other | $8,564 |
| Total | $2,175,226 |
Young received $1.6M in option awards, accounting for 72% of the total pay in 2023.
Young also received $149K in non-equity incentive plan, $459K in salary and $8.6K in other compensation.
Rankings
In 2023, Rodney Young's compensation ranked 478th out of 2,996 executives tracked by ExecPay. In other words, Young earned more than 84.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 478 out of 2,996 | 84th |
Division Manufacturing | 274 out of 1,640 | 83rd |
Major group Chemicals And Allied Products | 188 out of 909 | 79th |
Industry group Drugs | 185 out of 872 | 79th |
Industry Pharmaceutical Preparations | 116 out of 630 | 82nd |
Source: SEC filing on April 5, 2024.
Young's colleagues
We found two more compensation records of executives who worked with Rodney Young at RAPT Therapeutics in 2023.